Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

References for PMC Articles for PubMed (Select 21551244)

1.

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.

Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL; WHI Investigators.

JAMA. 2010 Oct 20;304(15):1684-92. doi: 10.1001/jama.2010.1500.

PMID:
20959578
2.

Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry.

Phillips KA, Milne RL, West DW, Goodwin PJ, Giles GG, Chang ET, Figueiredo JC, Friedlander ML, Keegan TH, Glendon G, Apicella C, O'Malley FP, Southey MC, Andrulis IL, John EM, Hopper JL.

Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1792-7. doi: 10.1158/1055-9965.EPI-08-1014. Erratum in: Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2345.

3.

Risk factors for the incidence of breast cancer: do they affect survival from the disease?

Barnett GC, Shah M, Redman K, Easton DF, Ponder BA, Pharoah PD.

J Clin Oncol. 2008 Jul 10;26(20):3310-6. doi: 10.1200/JCO.2006.10.3168.

4.

Oral contraceptives and the risk of death from breast cancer.

Wingo PA, Austin H, Marchbanks PA, Whiteman MK, Hsia J, Mandel MG, Peterson HB, Ory HW.

Obstet Gynecol. 2007 Oct;110(4):793-800. Erratum in: Obstet Gynecol. 2008 Feb;111(2 Pt 1):454.

PMID:
17906011
5.

Oral contraceptives and survival in breast cancer patients aged 20 to 54 years.

Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Moorman PG, Kaufman JS, Cai J, Porter PL, Brinton LA, Eley JW, Coates RJ.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1822-7.

6.

Regional variations in breast cancer among california teachers.

Reynolds P, Hurley S, Goldberg DE, Anton-Culver H, Bernstein L, Deapen D, Horn-Ross PL, Peel D, Pinder R, Ross RK, West D, Wright WE, Ziogas A.

Epidemiology. 2004 Nov;15(6):746-54.

PMID:
15475725
7.

High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States).

Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, Pinder R, Reynolds P, Sullivan-Halley J, West D, Wright W, Ziogas A, Ross RK.

Cancer Causes Control. 2002 Sep;13(7):625-35.

PMID:
12296510
8.

Oral contraceptives and the risk of breast cancer.

Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG, Daling JR, Bernstein L, Malone KE, Ursin G, Strom BL, Norman SA, Wingo PA, Burkman RT, Berlin JA, Simon MS, Spirtas R, Weiss LK.

N Engl J Med. 2002 Jun 27;346(26):2025-32.

9.

Hormonal and other factors in relation to survival among breast cancer patients.

Reeves GK, Patterson J, Vessey MP, Yeates D, Jones L.

Int J Cancer. 2000 May 20;89(3):293-9.

PMID:
10861507
10.

Diet and risk for breast cancer recurrence and survival.

Saxe GA, Rock CL, Wicha MS, Schottenfeld D.

Breast Cancer Res Treat. 1999 Feb;53(3):241-53.

PMID:
10369070
11.

The effect of oral contraceptive use on the prognosis of node positive breast cancer patients. German Breast Cancer Study Group.

Sauerbrei W, Blettner M, Schmoor C, Bojar H, Schumacher M.

Eur J Cancer. 1998 Aug;34(9):1348-51.

PMID:
9849415
12.

Prognostic significance of etiological risk factors in early breast cancer.

Schouten LJ, Hupperets PS, Jager JJ, Volovics L, Wils JA, Verbeek AL, Blijham GH.

Breast Cancer Res Treat. 1997 May;43(3):217-23.

PMID:
9150901
15.
16.

Oral contraceptive use and the prognosis of breast cancer.

Schönborn I, Nischan P, Ebeling K.

Breast Cancer Res Treat. 1994;30(3):283-92.

PMID:
7981446
17.

Oral contraceptives and breast cancer: final report of an epidemiological study.

Vessey M, Baron J, Doll R, McPherson K, Yeates D.

Br J Cancer. 1983 Apr;47(4):455-62.

18.

Influence of oral contraceptives on the prognosis of breast cancer in young women.

Rosner D, Lane WW, Perez Brett R.

Cancer. 1985 Apr 1;55(7):1556-62.

PMID:
3978550
19.

Oral contraceptive use has no adverse effect on the prognosis of breast cancer.

Rosner D, Lane WW.

Cancer. 1986 Feb 1;57(3):591-6.

PMID:
3942995
20.

Oral contraceptives and survival in breast cancer.

Millard FC, Bliss JM, Chilvers CE, Gazet JC.

Br J Cancer. 1987 Sep;56(3):377-8. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk